Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Carla V. Rodriguez"'
Autor:
Carla V. Rodriguez-Watson, Anthony M. Louder, Carly Kabelac, Christopher M. Frederick, Natalie E. Sheils, Elizabeth H. Eldridge, Nancy D. Lin, Benjamin D. Pollock, Jennifer L. Gatz, Shaun J. Grannis, Rohit Vashisht, Kanwal Ghauri, Camille Knepper, Sandy Leonard, Peter J. Embi, Garrett Jenkinson, Reyna Klesh, Omai B. Garner, Ayan Patel, Lisa Dahm, Aiden Barin, Dan M. Cooper, Tom Andriola, Carrie L. Byington, Bridgit O. Crews, Atul J. Butte, Jeff Allen
Publikováno v:
PLoS ONE, Vol 18, Iss 2 (2023)
Background Real-world performance of COVID-19 diagnostic tests under Emergency Use Authorization (EUA) must be assessed. We describe overall trends in the performance of serology tests in the context of real-world implementation. Methods Six health s
Externí odkaz:
https://doaj.org/article/b159237a09ca4d6fa2cba7bc84966748
Autor:
Carla V. Rodriguez-Watson, Natalie E. Sheils, Anthony M. Louder, Elizabeth H. Eldridge, Nancy D. Lin, Benjamin D. Pollock, Jennifer L. Gatz, Shaun J. Grannis, Rohit Vashisht, Kanwal Ghauri, Gina Valo, Aloka G. Chakravarty, Tamar Lasky, Mary Jung, Stephen L. Lovell, Jacqueline M. Major, Carly Kabelac, Camille Knepper, Sandy Leonard, Peter J. Embi, William G. Jenkinson, Reyna Klesh, Omai B. Garner, Ayan Patel, Lisa Dahm, Aiden Barin, Dan M. Cooper, Tom Andriola, Carrie L. Byington, Bridgit O. Crews, Atul J. Butte, Jeff Allen
Publikováno v:
PLoS ONE, vol 18, iss 2 February
PloS one, vol 18, iss 2
PloS one, vol 18, iss 2
Background As diagnostic tests for COVID-19 were broadly deployed under Emergency Use Authorization, there emerged a need to understand the real-world utilization and performance of serological testing across the United States. Methods Six health sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6566377936e48dac081ffa7f6a3ed5a2
https://escholarship.org/uc/item/8rx9p907
https://escholarship.org/uc/item/8rx9p907
Autor:
Carla V Rodriguez-Watson, Jennifer Vincent, Sheri Trudeau, Fold Investigators, Robert J. Romanelli, Jia Li, Irina V. Haller, Heather Anderson, Yihe G. Daida, Stuart C. Gordon, Mei Lu, Amandeep Sahota, Keith D. Lindor, Jeffrey J. VanWormer, Loralee B Rupp, Christopher L. Bowlus, Joseph A. Boscarino, Mark A Schmidt
Publikováno v:
Clinical Epidemiology. 12:1261-1267
Author(s): Lu, Mei; Bowlus, Christopher L; Lindor, Keith; Rodriguez-Watson, Carla V; Romanelli, Robert J; Haller, Irina V; Anderson, Heather; VanWormer, Jeffrey J; Boscarino, Joseph A; Schmidt, Mark A; Daida, Yihe G; Sahota, Amandeep; Vincent, Jennif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41031097e0d5587e18b716b92ab95e8f
https://doi.org/10.2147/clep.s262558
https://doi.org/10.2147/clep.s262558
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:86-96
Background Interferon-free direct-acting antivirals (DAAs) were introduced in 2013 and have transformed the therapeutic landscape for chronic Hepatitis C (HCV). Although treatment is recommended for almost all persons infected with HCV, clinical and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7442074b9f0e35ccb279b72730d1d99d
https://doi.org/10.1002/pds.5138
https://doi.org/10.1002/pds.5138
Autor:
Taruja Karmarkar, Carla V. Rodriguez-Watson, Eric Watson, Hanke Zheng, Darrell J. Gaskin, William V. Padula
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 25(9)
This study aimed to assess the cost-effectiveness of fibrosis-based direct-acting antiviral treatment policies for patients with chronic hepatitis C virus at the Kaiser Permanente Mid-Atlantic States health system.We used a Markov model to compare th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccfc0bc5b904f1dceea92a49783ef4dd
https://pubmed.ncbi.nlm.nih.gov/35484030
https://pubmed.ncbi.nlm.nih.gov/35484030
Autor:
Carla V Rodriguez-Watson, Amy C. Justice, Seth Kuranz, Frank de Wolf, Tom Brown, Nicolle M. Gatto, Anna Siefkas, Andrew Weckstein, Elizabeth Eldridge, Kelly Cho, Yuk-Lam Ho, Julius Asubonteng, Samson Mataraso, Daniel C Posner, Adem Albayrak, Carson Lam, Ritankar Das, Stuart L. Goldberg, Jonathan Hirsch, Andrew J. Belli, Qingqing Mao, Andrew Schrag, Ellen V. Sigal, Mark Stewart, Alice Gelman, Georgia D. Tourassi, Monika A Izano, Reyna Klesh, Amar Bhat, Andrew Ip, Eric Hansen, Susan C. Winckler, Hanna Gerlovin, Jeremy A. Rassen, Jeff Allen, Jason Jones, Robertino Mera
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248128 (2021)
PLoS ONE
PLoS ONE
Background The COVID-19 pandemic remains a significant global threat. However, despite urgent need, there remains uncertainty surrounding best practices for pharmaceutical interventions to treat COVID-19. In particular, conflicting evidence has emerg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::286cb7ce58be37878f5d7ef45b22f18a
https://doaj.org/article/54f31913ca1947ed9d201427eb11393b
https://doaj.org/article/54f31913ca1947ed9d201427eb11393b
Autor:
Heather Anderson, Irina V. Haller, Robert J. Romanelli, Kuan-Han Hank Wu, Jia Li, Amandeep Sahota, Sheri Trudeau, Fold Investigators, Loralee B Rupp, Stuart C. Gordon, Mei Lu, Mark A Schmidt, Christopher L. Bowlus, Talan Zhang, Jeffrey J. VanWormer, Carla V. Rodriguez, Jennifer Vincent, Joseph A. Boscarino, Keith D. Lindor, Yihe G. Daida
Publikováno v:
The American journal of gastroenterology. 115(2)
Background We used data from the Fibrotic Liver Disease Consortium to evaluate the impact of ursodeoxycholic acid (UDCA) treatment across race/ethnicity, gender, and clinical status among patients with primary biliary cholangitis. Methods Data were c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2072d787ac4cde1aa8eddbf1cab36027
https://pubmed.ncbi.nlm.nih.gov/31985529
https://pubmed.ncbi.nlm.nih.gov/31985529
Autor:
Heidi M. Crane, Heidi E. Hutton, Stephen E. Van Rompaey, Michael J. Mugavero, Richard D. Moore, Joseph J. Eron, Katerina A. Christopoulos, Mari M. Kitahata, Michael S. Saag, Joseph O. Merrill, H. Nina Kim, Geetanjali Chander, Sonia Napravnik, Elvin Geng, Edward R. Cachay, Carla V. Rodriguez, Kenneth H. Mayer, Mary E. McCaul
Publikováno v:
AIDS and Behavior. 21:1878-1884
We examined risk factors for advanced hepatic fibrosis [fibrosis-4 (FIB)-4 >3.25] including both current alcohol use and a diagnosis of alcohol use disorder among HIV-infected patients. Of the 12,849 patients in our study, 2133 (17%) reported current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb002f16b6f337b43bd450c5ec31d04d
https://doi.org/10.1007/s10461-016-1665-6
https://doi.org/10.1007/s10461-016-1665-6
Autor:
Heidi M. Crane, Robin M. Nance, Amy C. Justice, Joon Kim, Amir Sharafkhaneh, Shahida Shahrir, Kristina Crothers, Kathleen M. Akgün, Guy W. Soo Hoo, Carla V. Rodriguez
Purpose No prior studies have addressed the performance of electronic health record (EHR) data to diagnose chronic obstructive pulmonary disease (COPD) in people living with HIV (PLWH), in whom COPD could be more likely to be underdiagnosed or misdia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da4435bbb9f41d49448d820626fcf34
https://europepmc.org/articles/PMC6309326/
https://europepmc.org/articles/PMC6309326/
Autor:
Michael A. Horberg, Stephen F. Derose, Jean Marie Arduino, Rong Wei, Kevin B Rubenstein, Sara Y. Tartof, Lei Qian, Jin-Wen Hsu, Carla V. Rodriguez, Haihong Hu
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 13(10)
BACKGROUND AND OBJECTIVES: Studies evaluating the role of hepatitis C viral (HCV) infection on the progression of CKD are few and conflicting. Therefore, we evaluated the association of untreated HCV on kidney function decline in patients with stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640bee2900d911695b99d49b38dc4bc8
https://pubmed.ncbi.nlm.nih.gov/30242027
https://pubmed.ncbi.nlm.nih.gov/30242027